Skip to main content

Want a detailed portfolio tracker?

Mesoblast (MESO) P/E (2015 - 2026)

Mesoblast (MESO) P/E from Nov 13, 2015 to Jul 21, 2026. The TTM Mesoblast (MESO) P/E is -22.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mesoblast (MESO)

YearP/EChange
2026-22.29-8.98%
2025-24.49+13.03%
2024-21.67+879.31%
2023-2.21-50.54%
2022-4.47-28.74%
2021-6.28-35.56%
2020-9.74-1.82%
2019-9.92+115.92%
2018-4.60-53.14%
2017-9.81-90.15%
2016-99.58+1522.30%
2015-6.14N/A

Comparison Mesoblast (MESO) P/E with competitors

Mesoblast (MESO) P/E is -22.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.34%
FGENFibroGen Inc0.24-101.08%
CHRSCoherus Biosciences Inc0.85-103.81%
FBIOFortress Biotech Inc0.95-104.26%
ORMPOramed Pharmaceuticals Inc1.50-106.74%
AGENAgenus Inc3.01-113.50%
INVAInnoviva Inc3.15-114.15%
VXRTVaxart Inc3.55-115.92%
CRMDCorMedix Inc3.63-116.27%
CVACCureVac N.V.4.45-119.94%
GLPGGalapagos NV4.86-121.79%
SRPTSarepta Therapeutics Inc4.88-121.90%
ABEOAbeona Therapeutics Inc5.39-124.16%
ABUSArbutus Biopharma Corp5.60-125.10%
ZVRAZevra Therapeutics Inc5.89-126.41%
SPROSpero Therapeutics Inc6.23-127.94%
CGENCompugen Ltd6.31-128.32%
RIGLRigel Pharmaceuticals6.87-130.82%
SLXNSilexion Therapeutics Corp7.30-132.72%
OMEROmeros Corporation9.26-141.53%
AUPHAurinia Pharmaceuticals Inc9.58-142.99%
PLXProtalix BioTherapeutics Inc10.89-148.85%
ACADAcadia Pharmaceuticals Inc11.73-152.60%
TBPHTheravance Biopharma Inc12.26-155.00%
ADMAAdma Biologics Inc12.42-155.70%
HRMYHarmony Biosciences Holdings Inc13.82-161.99%
SABSSAB Biotherapeutics Inc14.14-163.40%
NAGENiagen Bioscience Inc14.82-166.46%
INCYIncyte Corp15.82-170.97%
REGNRegeneron Pharmaceuticals Inc15.86-171.12%
PBYIPuma Biotechnology Inc17.32-177.66%
CPRXCatalyst Pharmaceuticals Inc17.44-178.22%
EXELExelixis Inc17.54-178.66%
TGTXTG Therapeutics Inc18.97-185.07%
MDXGMimedx Group Inc20.55-192.18%
XOMAXOMA Royalty Corp22.87-202.60%
ARGXArgen X SE24.30-208.98%
CTMXCytomX Therapeutics Inc24.82-211.33%
XOMAOXOMA Royalty Corp25.34-213.68%
HALOHalozyme Therapeutics Inc25.62-214.93%
XOMAPXOMA Royalty Corp25.67-215.14%
VRTXVertex Pharmaceuticals Inc27.99-225.57%
RPRXRoyalty Pharma plc - Class A28.69-228.67%
SLNOSoleno Therapeutics Inc29.02-230.14%
ASNDAscendis Pharma A/S30.09-234.94%
LGNDLigand Pharmaceuticals Inc - Class B37.91-270.05%
APLSApellis Pharmaceuticals Inc39.02-275.02%
BMRNBiomarin Pharmaceutical Inc42.21-289.33%
KRYSKrystal Biotech Inc45.34-303.38%
ONCBeiGene Ltd69.54-411.91%
PHARPharming Group N.V.75.03-436.51%
TECHBio-Techne Corp101.96-557.32%
VCELVericel Corp109.92-593.03%
ALNYAlnylam Pharmaceuticals Inc117.96-629.11%
GMABGenmab140.29-729.25%
TLXTelix Pharmaceuticals Ltd162.15-827.31%
CORTCorcept Therapeutics Inc212.86-1054.73%